STOCK TITAN
  1. Home
  2. News
  3. HIMS

Hims & Hers Health, Inc. - HIMS STOCK NEWS

Welcome to our dedicated page for Hims & Hers Health news (Ticker: HIMS), a resource for investors and traders seeking the latest updates and insights on Hims & Hers Health stock.

Hims & Hers Health, Inc. (HIMS) is a cutting-edge telehealth company, headquartered in San Francisco, California, that revolutionizes the way people access healthcare. Founded in 2013, the company provides a multi-specialty platform connecting consumers to licensed healthcare professionals, offering a seamless path to high-quality medical care for various conditions.

Hims & Hers Health, Inc. specializes in a broad range of wellness products and services. Their portfolio includes treatments for hair loss, sexual wellness products, skincare lines, and oral care solutions. The company also diversifies its offerings through an exclusive range of men's fashion items including sweaters, jackets, corduroy, sport coats, wool overcoats, leather boots, flannel shirts, caps, and candles. All products are conveniently available for purchase through their online platform.

The telehealth services provided by Hims & Hers are comprehensive, covering mental health, sexual health, dermatology, primary care, and more. This robust platform ensures consumers receive professional medical consultations from the comfort of their homes.

Hims & Hers Health, Inc. continues to innovate and expand its services to meet the evolving needs of its customers. Recent achievements include advancements in their telehealth technology, expanding partnerships with renowned medical professionals, and enhancing their product lines. The company is financially sound and continues to grow, reflecting positive market performance and consumer trust.

For the latest updates, financial reports, and company news, Hims & Hers Health remains a significant player in both the wellness product market and the telehealth industry.

News

Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer

Rhea-AI Summary
Hims & Hers Health, Inc. announced the appointment of Dan Kenger as the Chief Design Officer to enhance the brand's digital-first health and wellness experience. Kenger's role involves overseeing design across the organization to create a personalized customer journey. With a background in creative leadership, Kenger aims to build trust and improve lives through innovative design.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.19%
Tags
none
-
News

Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

Rhea-AI Summary
Hims & Hers Health, Inc. (NYSE: HIMS) will report Q4 and full year 2023 financial results on February 26, 2024. A live conference call will discuss the results, with upcoming participation in the Morgan Stanley Technology, Media & Telecom Conference on March 6, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.05%
Tags
earnings
-
News

Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care

Rhea-AI Summary
Hims & Hers Health, Inc. (NYSE: HIMS) partners with Hartford HealthCare to expand access to high-quality healthcare services in Connecticut.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.51%
Tags
none
News

Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss

Rhea-AI Summary
Hims & Hers Health, Inc. (NYSE: HIMS) introduces Weight Loss by Hims & Hers, a personalized and affordable clinical program to help people achieve their weight-loss goals. Dr. Craig Primack, a pioneer in clinical obesity medicine, joins as SVP of Weight Management. The program is designed to address the underlying factors affecting weight through a holistic approach, combining medication management, digital tracking tools, and customized educational content.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.68%
Tags
none
-
News

Hims & Hers Health, Inc. Announces $50 Million Share Repurchase Program Authorization

Rhea-AI Summary
Hims & Hers Health, Inc. announces a share repurchase program of up to $50 million of outstanding Class A common stock over the next two years. The program will be used to repurchase shares on a discretionary basis. The decision is driven by the Company's strong business performance and belief that its shares are trading below their intrinsic value. In the third quarter of 2023, revenue was up 57% YoY to $226.7 million, and the Company surpassed 1.4 million subscribers. Full-year revenue is expected to be between $868 and $873 million, up 65% to 66% YoY.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.99%
Tags
buyback
-
News

Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook

Rhea-AI Summary
Hims & Hers Health, Inc. reported strong financial results for Q3 2023, with revenue of $226.7 million, up 57% YoY, and a net loss of $7.6 million. The company achieved adjusted EBITDA profitability of $12.3 million. Subscribers grew to 1.4 million, up 56% YoY. Hims & Hers raised its full-year 2023 revenue guidance to a range of $868 million to $873 million and adjusted EBITDA guidance to a range of $43 million to $46 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.99%
Tags
earnings
News

Hims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic Services

Rhea-AI Summary
Hims & Hers introduces MedMatch, a technology that uses AI and machine learning to deliver personalized healthcare solutions. Currently in Beta, MedMatch identifies treatments in real-time based on a patient's unique needs. It aims to bridge the gap between need and access in mental health care. MedMatch is being evaluated on metrics like remission rates and patient satisfaction.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.09%
Tags
none
-
News

Hims & Hers Names Khobi Brooklyn As Chief Communications Officer

Rhea-AI Summary
Hims & Hers appoints Khobi Brooklyn as Chief Communications Officer to strengthen the brand and increase awareness
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.31%
Tags
none
-
News

Hims & Hers to Announce Third Quarter 2023 Financial Results on November 6, 2023

Rhea-AI Summary
Hims & Hers Health to report Q3 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
earnings
News

Hims & Hers Health, Inc. Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Outlook

Rhea-AI Summary
Hims & Hers reports Q2 2023 revenue of $207.9 million, up 83% YoY. Net loss of $7.2 million; Adjusted EBITDA profitability of $10.6 million. Subscribers grew to 1.3 million, up 74% YoY. Raises full year 2023 revenue guidance to $830M-$850M and Adjusted EBITDA guidance to $35M-$40M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.82%
Tags
earnings

FAQ

What is the current stock price of Hims & Hers Health (HIMS)?

The current stock price of Hims & Hers Health (HIMS) is $24.15 as of November 21, 2024.

What is the market cap of Hims & Hers Health (HIMS)?

The market cap of Hims & Hers Health (HIMS) is approximately 4.9B.

What does Hims & Hers Health, Inc. do?

Hims & Hers Health, Inc. is a telehealth company offering wellness products and connecting consumers to licensed healthcare professionals for various medical conditions.

Where is Hims & Hers Health, Inc. based?

The company is based in San Francisco, California.

When was Hims & Hers Health, Inc. founded?

The company was founded in 2013.

What types of products does Hims & Hers offer?

Hims & Hers offers hair loss prevention medicines, sexual wellness products, skincare products, oral care solutions, as well as men's fashion items like sweaters, jackets, and leather boots.

What medical services are available through Hims & Hers?

The company provides telehealth services covering mental health, sexual health, dermatology, primary care, and more.

How can I purchase products from Hims & Hers?

Products are available for purchase online through their platform.

How is Hims & Hers Health, Inc. performing financially?

Hims & Hers Health, Inc. is financially sound and continues to grow, reflecting positive market performance.

What recent achievements has Hims & Hers Health, Inc. made?

Recent achievements include advancements in telehealth technology, expanding partnerships with medical professionals, and enhancing product lines.

Does Hims & Hers collaborate with healthcare professionals?

Yes, Hims & Hers connects consumers with licensed healthcare professionals for consultations and medical care.

What makes Hims & Hers Health, Inc. unique?

Hims & Hers combines a broad range of wellness products with comprehensive telehealth services, enabling convenient access to high-quality medical care from home.

Stock HIMS logo
Hims & Hers Health, Inc.

NYSE:HIMS

HIMS Rankings

#1317 Ranked by Market Cap
N/A Ranked by Dividends

HIMS Stock Data

4.94B
184.38M
11.39%
66.19%
15.54%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
SAN FRANCISCO